← Leaderboards
Andrew R Mendelsohn
Panorama Research, Inc.
$3,743,233
Attributed
$5,483,533
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2008–24$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,483,533 · 15
By mechanism
R43$3,989,920 · 14
R44$1,493,613 · 1
Top collaborators
- James W Larrick9 shared
- John C. Cambier2 shared
- Bo Yu2 shared
- Batbileg Bor1 shared
- Andrzej Fertala1 shared
- Shawn Mojtahedian1 shared
- Xiaoming Zhang1 shared
Most similar at Panorama Research, Inc.
Same institution · by research overlap
- James W Larrick$19,609,694
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesIn VitroAffectDrug KineticsIn VivoLeadToxic EffectPre-ClinicalAttenuatedAffinityAmericanMouse ModelMediatingToxicologyAntibody TherapyAnimal ModelCellsProteinsPreparationTissuesClinical TrialsLinkAssay DevelopmentSignal Transduction
Grant awards (17)
Novel therapy to prevent alveolar bone loss in severe periodontitis$304,019
R43 · FY2024 · DE
Silencing autoantibody secretion for SLE therapy$299,773
R43 · FY2024 · AI · contact PI
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia$299,989
R43 · FY2023 · NS
Silencing autoantibody secretion for SLE therapy$299,865
R43 · FY2023 · AI · contact PI
Therapy for ectopic calcification in pseudoxanthoma elasticum$285,766
R43 · FY2023 · AR · contact PI
Novel therapy for arthrofibrosis$275,765
R43 · FY2023 · AR
Improved carnosic acid congener compounds for Alzheimerâs disease$326,205
R43 · FY2022 · AG · contact PI
Therapeutic antibody for hyperemesis gravidarum$300,847
R43 · FY2022 · HD · contact PI
Dual Intracellular and Extracellular Expression Technology (dIEE) for Parkinsonâs Disease$225,000
R43 · FY2019 · NS
Rational antibody therapy for IPF$758,362
R44 · FY2018 · HL · contact PI
Dual Intracellular and Extracellular Expression Technology (dIEE) for AlzheimerÃÂÃÂÃÂâÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂs Disease$224,981
R43 · FY2018 · AG
Rational antibody therapy for IPF$735,251
R44 · FY2017 · HL · contact PI
Rational antibody therapy for IPF$223,800
R43 · FY2015 · HL · contact PI
Novel Targeted Cytokine for Chronic Kidney Disease$224,243
R43 · FY2014 · DK · contact PI
Tunable Frataxin Replacement Therapy$218,589
R43 · FY2014 · NS · contact PI
Novel Regenerative Therapy for Myocardial Infarction$289,018
R43 · FY2011 · HL · contact PI
Novel TACE Inhibitors for Breast Cancer Therapy$192,060
R43 · FY2008 · CA · contact PI